✦ LIBER ✦

Barriers to the long-term use of low-molecular weight heparins for treatment of cancer-associated thrombosis

✍ Scribed by A. K. WITTKOWSKY

Book ID: 109151667
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 473 KB
Volume: 4
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2006.02073.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Home treatment of deep venous thrombosis

Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism

✍ Enric Grau; Jose M. Tenias; Esperanza Real; Jose Medrano; Rosario Ferrer; Emilio 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB 👁 2 views

## Abstract Outpatient treatment of deep venous thrombosis (DVT) with low molecular weight heparin (LMWH) seems as safe and effective as inpatient treatment with unfractionated heparin (UFH). However, most of the randomized trials comparing a LMWH with UFH described clinical outcomes within 3–6 mon

Low-molecular-weight Heparin for the tre

Low-molecular-weight Heparin for the treatment of venous thrombosis in patients with adenocarcinoma

✍ Eikelboom, John W.; Baker, Ross I. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB 👁 2 views

This case further supports

Cost-minimization analysis of low-molecu

Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis

✍ Elenir B. C. Avritscher; Scott B. Cantor; Ya-Chen T. Shih; Carmelita P. Escalant 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 154 KB

Long-term use of daily subcutaneous low

Long-term use of daily subcutaneous low molecular weight heparin in cancer patients with venous thromboembolism: why hesitate any longer?

✍ Philippe Debourdeau; Ismail Elalamy; Axelle de Raignac; Paul Meria; Jean Marc Go 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 194 KB

High vs. low doses of low-molecular-weig

High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial

✍ THE VESALIO INVESTIGATORS GROUP 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Patients requiring interruption of long-

Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin

✍ A. MALATO; G. SACCULLO; L. LO COCO; D. CARAMAZZA; I. ABBENE; G. PIZZO; A. CASUC 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB